Risk For Multidrug- And Rifampicin-Resistant TB Recurrence Is Low Following Long-Term Treatment With Bedaquiline Or Delamanid, Study Finds

Infectious Disease Advisor (10/26, Nye) reports, “The risk for multidrug (MDR)- and rifampicin-resistant tuberculosis (TB) recurrence is low following long-term treatment with bedaquiline or delamanid, according to results of a study published in Clinical...